Biopharma Partner Services
Latest CDx Indication
FoundationOne®Liquid CDx has been approved by the FDA as the only blood-based comprehensive genomic profiling (CGP) companion diagnostic (CDx) for Tabrecta® (capmatinib).
Biopharma Partner FAQ
Join us at AUA 2021
Foundation Medicine will attend the virtual American Urological Association Annual Meeting September 10-13, 2021. | Learn more